Indicators

Markets:

News

Latest News about CANF

Recent news which mentions CANF

< Previous 1 2 Next >

Why Is Canoo Surging By 80%? 52 Stocks Moving In Tuesday's Mid-Day Session

July 12, 2022

Alibaba, Zoom Video And 76 Biggest Movers From Yesterday

July 12, 2022

The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After

July 11, 2022

Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday

July 01, 2022

Why Is NeuroSense Therapeutics Jumping By 45%? 64 Stocks Moving In Thursday's Mid-Day Session

June 30, 2022

Aspen Aerogels And 28 Stocks Moving Premarket

June 30, 2022

This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday

June 30, 2022

The Daily Biotech Pulse: Eli Lilly Modifies COVID-19 Treatment Pact, Oyster Point Outlines Restructuring Plan, Icosavax Posts Interim RSV Vaccine Data

June 29, 2022

Can-Fite BioPharma Shares Jump After Piclidenoson Data In Psoriasis Trial

June 29, 2022

Can Fite Biofarma: Q1 Earnings Insights

May 26, 2022

Can-Fite Q1 Revenue Increases 38.5%, Phase III Psoriasis Treatment Study Results Expected In Q2

May 26, 2022

Attacking Diseases On Multiple Fronts — Pharmaceutical Development Combined With Cannabis?

April 12, 2022

Can-Fite Reports Revenue Growth In 2021, Provides Clinical Update

March 24, 2022

This Biotech Company Looks To Be Targeting A New Drug To Treat NASH, The Leading Cause of Liver Transplants

March 24, 2022

Can-Fite To Reveal Findings In Treatment Of Liver Cancer And Fibrosis With Cannabinoids At CannX

March 11, 2022

Can-Fite BioPharma Flags Delay In Piclidenoson Data Readout From Psoriasis Study

March 08, 2022

CANF: Beginning to Flex Its Muscles; Initiating With OUTPERFORM Rating, $6.00 Price Target

February 23, 2022

Psoriasis Drug Providers Looking Over Shoulders At Upcoming Competitor?

February 03, 2022

A New Oral Therapy for Psoriasis Could Be Coming Soon

January 24, 2022

Can Fite's Piclidenoson Destroys Pathological Skin Cells, Lab Study Shows

January 13, 2022

The Daily Biotech Pulse: Adagio's Antibody Effective Against Omicron, Sarepta Terminates Gene Therapy Deal, AstraZeneca Inks Oncology Pact

January 13, 2022

PRIOR TO PHASE III PSORIASIS DATA RELEASE CAN FITE REPORTS THAT PICLIDENOSON DESTROYS PATHOLOGICAL SKIN CELLS IN VITRO

January 13, 2022

Can-Fite to Conduct Investor Meetings during the J.P. Morgan Healthcare Conference

January 10, 2022

CAN-FITE ISSUES LETTER TO SHAREHOLDERS

January 05, 2022

FOLLOWING COMPLETE CLEARANCE OF CANCER LESIONS IN ADVANCED LIVER CANCER PATIENT, CAN-FITE IS FILING PATENT APPLICATIONS FOR THE TREATMENT OF VARIOUS ADVANCED SOLID TUMORS

January 03, 2022

45 Biggest Movers From Yesterday

December 30, 2021

26 Stocks Moving In Wednesday's Mid-Day Session

December 29, 2021

CANF Stock: The Cancer-Fighting News Sending Can-Fite Higher Today

December 29, 2021

55 Biggest Movers From Yesterday

December 22, 2021

38 Stocks Moving In Tuesday's Mid-Day Session

December 21, 2021

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.